MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction

The detection of specific alterations by genetic analyses has been included in the diagnostic criterions of the World Health Organization’s classification of soft tissues tumors since 2013. The presence of a SS18 rearrangement is pathognomonic of synovial sarcoma (SS). MDM2 amplification is strongly...

Full description

Bibliographic Details
Main Authors:	Ilaria Di Mauro, Lénaïg Mescam-Mancini, Bruno Chetaille, Marick Lae, Gaelle Pierron, Bérengère Dadone-Montaudie, Audrey Bazin, Corinne Bouvier, Jean-François Michiels, Florence Pedeutour
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	Neoplasia: An International Journal for Oncology Research
Subjects:	Synovial sarcoma Amplification Diagnosis Liposarcoma MDM2
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558620301202

Similar Items

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
by: Bérengère Dadone-Montaudié, et al.
Published: (2020-10-01)

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
by: Audrey Laroche-Clary, et al.
Published: (2017-06-01)

A single institutional experience treating adipocytic tumors: incidence, disease-related outcomes, and the clinical significance of MDM2 analysis
by: Saule Tamkus, et al.
Published: (2020-11-01)

Rare aggressive behavior of MDM2-amplified retroperitoneal dedifferentiated liposarcoma, with brain, lung and subcutaneous metastases
by: Imen Ben Salha, et al.
Published: (2016-10-01)

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
by: Shomereeta Roy, et al.
Published: (2020-08-01)

MDM2 Amplified Sarcomas: A Literature Review
by: Raf Sciot
Published: (2021-03-01)

Primary pleural liposarcoma combined spindle cell lipoma of the lung
by: Lae Hyung Kang, et al.
Published: (2020-07-01)

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
by: Andrew Patt, et al.
Published: (2020-08-01)

Critical histopathological analysis of 25 dedifferentiated liposarcomas, including uncommon variants, reviewed at a Tertiary Cancer Referral Center
by: Bharat Rekhi, et al.
Published: (2012-01-01)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
by: Johanna Huun, et al.
Published: (2017-04-01)

Retroperitoneal Liposarcoma: Current Insights in Diagnosis and Treatment
by: Lucas eMatthyssens, et al.
Published: (2015-02-01)

Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
by: Agnė Bartnykaitė, et al.
Published: (2021-02-01)

Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion
Published: (2007)

First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report
by: Denise Buchner, et al.
Published: (2018-12-01)

Primary colonic well-differentiated / dedifferentiated liposarcoma of the ascending colon: a case report
by: Hiroshi Sawayama, et al.
Published: (2017-08-01)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01)

Dedifferentiated liposarcoma with heterologous spindle cell rhabdomyoblastic de-differentiation: An unusual pattern expanding the morphological spectrum
by: Bharat Rekhi, et al.
Published: (2020-01-01)

Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma
by: Rosalvo Zósimo Bispo Júnior, et al.
Published: (2008-01-01)

Rare Cause of Dysphagy: Giant Polypoid Esophageal Well-Differentiated Liposarcoma
by: Ladislav Mica, et al.
Published: (2007-06-01)

Primary colonic liposarcomatosis: report of a case with review of literature
by: Mahesh Sultania, et al.
Published: (2019-08-01)

Targeting MDM4 Splicing in Cancers
by: Boris Bardot, et al.
Published: (2017-02-01)

Alternative Splicing of MDM4 in Human Melanomas
by: Alatawi, Abdullah Salem S.
Published: (2020)

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
by: Pavlína Kosztyu, et al.
Published: (2019-04-01)

MDM2–MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance
by: Moscetti I, et al.
Published: (2016-08-01)

Sarcomas of fat and bone: a case report
by: Barkhausen, J., et al.
Published: (2022)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
by: Andrea Forschner, et al.
Published: (2020-02-01)

Overexpression and amplification of Murine double minute 2 as a diagnostic tool in large lipomatous tumor and its correlation with Ki67 proliferation index: An institutional experience
by: Rizky Ifandriani Putri, et al.
Published: (2014-01-01)

Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an <sup>18</sup>F-Labeled Analogue of the MDM2 Inhibitor SP-141
by: Satish K. Chitneni, et al.
Published: (2021-04-01)

<i>MDM2</i> Alternative Splicing: Regulators and Functions in Oncogenesis
by: Comiskey, Daniel Forrest, Jr.
Published: (2017)

Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
by: Chong Gao, et al.
Published: (2019-01-01)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
by: Ola A Bakry, et al.
Published: (2012-01-01)

Evolution of the p53-MDM2 pathway
by: Emma Åberg, et al.
Published: (2017-08-01)

Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells
by: Olga Egorova, et al.
Published: (2020-02-01)

Molecular Determinants of Alternative Splicing of MDM2 in Response to Stress: Implications in Pediatric Rhabdomyosarcoma
by: Singh, Ravi K.
Published: (2009)

A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population
by: Hasan Al Reza, et al.
Published: (2020-05-01)

GDSS Prototype Model for Supplier Selection at MDM Cooperative
by: Meri Azmi, et al.
Published: (2021-03-01)

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
by: Kentaro Miura, et al.
Published: (2021-06-01)

Design and numerical study of turbines operating with MDM as working fluid
by: Klonowicz Piotr, et al.
Published: (2015-12-01)

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
by: Asanuma Hiroko, et al.
Published: (2005-01-01)

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
by: Yuan Fang, et al.
Published: (2020-07-01)